| Christopher Alan Sanders, | |
|
703 17th St Nw, Aliceville, AL 35442-1426 | |
| (205) 463-7325 | |
| Not Available |
| Full Name | Christopher Alan Sanders |
|---|---|
| Gender | Male |
| Speciality | Occupational Therapist |
| Location | 703 17th St Nw, Aliceville, Alabama |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467107664 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 1805 (Alabama) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Christopher Alan Sanders, 5614 Joseph Hunters Cir, Tuscaloosa, AL 35405-7792 Ph: (205) 886-5676 | Christopher Alan Sanders, 703 17th St Nw, Aliceville, AL 35442-1426 Ph: (205) 463-7325 |
News Archive
As emergent pathogens like coronavirus and climate-related health challenges like wildfire smoke plague human populations, the University of Montana has received funding for a center dedicated to understanding and addressing public health challenges to Montana and the region.
Although the world is focused on the COVID-19 pandemic, there are many other dangerous pathogens still out there, like Yersinia pestis, which causes plague – the deadly disease that killed tens of millions of people during the infamous Black Death in the 14th century.
Sfter holding more than a dozen H1N1 influenza immunization clinics this fall targeting people in high-risk groups, the Macomb County Health Department announced today that it is opening its upcoming clinics to everyone 6 months of age and older.
According to Norma Erickson, President of SaneVax Inc., testimony provided for a coroner's inquest into the death of Jasmine Renata in New Zealand by Dr. Sin Hang Lee, a pathologist on the medical staff at Connecticut's Milford Hospital, revealed the discovery of HPV DNA fragments in post-mortem samples 6 months after Gardasil vaccination.
Micromet, Inc., a biopharmaceutical company focused on the development and commercialization of next-generation antibodies for the treatment of cancer, today announced that data on its lead product candidate blinatumomab (MT103) will be reported at the 53rd Annual American Society of Hematology (ASH) Annual Meeting, to be held December 10 - 13 in San Diego, California.
› Verified 8 days ago
Anna Katherine King, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 703 17th St Nw, Aliceville, AL 35442 Phone: 205-373-0275 |